Today, a Director at United Therapeutics (NASDAQ: UTHR), Richard Giltner, sold shares of UTHR for $419.2K. See today’s analyst top
Today, the President & CEO of Steadymed (NASDAQ: STDY), Jonathan Rigby, sold shares of STDY for $413.1K. See today’s analyst
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (NASDAQ:REGN) and Zealand Pharma
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perrigo Company
In a report released today, Andrew D’silva from B.Riley FBR maintained a Buy rating on Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX),
In a report released today, Leah R. Cann from Oppenheimer maintained a Hold rating on Editas Medicine Inc (NASDAQ: EDIT).
Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Evolus Inc (NASDAQ: EOLS) today and set a price target